ALSO READGranules India's subsidiary enters into product in-licensing agreement Granules India fixes record date for 1st interim dividend Granules India Q1 net up 37 pc at Rs 39 cr Granules India consolidated net profit rises 48.17% in the March 2016 quarter Granules India consolidated net profit rises 36.51% in the June 2016 quarter
Located at Hyderabad, TelanganaGranules India announced that Company's Gagillapur facility located at Hyderabad, Telangana, India has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)